2017 American Transplant Congress

Tuesday, May 2, 2017

6:00pm-7:00pm

Successful Implementation of a Pneumococcal Vaccination Program for Pediatric Kidney Transplant Recipients.

K. Sprott, S. Nadig, K. Twombley.

Poster Session D: Kidney: Pediatric  •  Hall D1

6:00pm-7:00pm

Superior Long-Term Hypertension Management in Pediatric Kidney Transplant Recipients with Bilateral Native Nephrectomies.

D. Stoltz,¹ A. Brubaker,¹ A. Chaudhuri,² P. Grimm,² W. Concepcion,¹ A. Gallo.¹

Poster Session D: Kidney: Pediatric  •  Hall D1

6:00pm-7:00pm

Systemic Meta-Analysis: Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients?

K. Jayant,¹ I. Reccia,² J. Walton,¹ A. Sharma,³ A. Halawa.¹

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Tacrolimus and Mycophenolate Exposure and Subclinical Tubulo-Interstitial Inflammation in Low Immunological Risk Renal Transplants.

I. Torres,¹ A. Reisaeter,² F. Moreso,¹ A. Asberg,² M. Perello,¹ C. Dörje,² J. Sellares,¹ K. Midtved,² H. Holdaas,² D. Seron.¹

Poster Session D: Kidney: Acute Cellular Rejection  •  Hall D1

6:00pm-7:00pm

Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients.

L. Qu, Z. Xie, H. Huang, H. Jiang, J. Chen, H. Jiang, H. Jiang, J. Chen, J. Chen, J. Chen.

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients.

S. Seibert,¹ D. Schladt,² B. Wu,³ W. Guan,³ C. Dorr,^2,7 D. Berglund,¹ R. Remmel,⁴ A. Matas,⁵ R. Mannon,⁶ A. Israni,^2,7 W. Oetting,¹ P. Jacobson,¹ For the DeKAF Genomics Investigators.

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Tacrolimus Pharmacogenomics: Association of Genetic Variants with Clinical Factors Including Tacrolimus Requirement, Clearance, Intraindividual Variability, and Coefficient Variation.

S.-Y. Kim,¹ J. Oh,² S. Yun,² I.-J. Jang,² S.-I. Min,¹ W. Cho,¹ S. Cho,¹ S. Ahn,¹ S.-K. Min,¹ J. Ha.¹

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Tangible Benefits in Caregiving Burden Among Spouses/Partners of Transplant Patients: Adding “Donor Benefit” to Live Donor Risk Assessment.

S. Rasmussen, L. Duquette, M. Henderson, D. Segev.

Poster Session D: Living Donor Kidney Transplant II  •  Hall D1

6:00pm-7:00pm

Technically Successful Miniaturization of Blood Hemofilters for an Artificial Kidney via Bioengineering Techniques.

R. Forbes,¹ C. Kensinger,¹ S. Karp,¹ J. Groszek,¹ A. Buck,² D. Colvin,² S. Roy,³ W. Fissell.¹

Poster Session D: Cellular & Bone Marrow Transplantation Session II  •  Hall D1

6:00pm-7:00pm

The Associations Between Immunosuppression Use, Loss of Medicare and Kidney Allograft Outcomes.

A. Hart,^1,2 S. Gustafson,² A. Wey,² N. Hadley,² A. Israni.²

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1